UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060669
Receipt number R000069280
Scientific Title A Randomized Controlled trial of a Psychoeducational Web Application for Social Anxiety in Social Situations.
Date of disclosure of the study information 2026/02/18
Last modified on 2026/02/13 17:23:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized Controlled Trial of a Psychoeducational Web Application for Social Anxiety in Social Situations.

Acronym

RCT of a Psychoeducational Web Application for Social Anxiety in Social Situations.

Scientific Title

A Randomized Controlled trial of a Psychoeducational Web Application for Social Anxiety in Social Situations.

Scientific Title:Acronym

RCT of a Psychoeducational Web Application for Social Anxiety in Social Situations.

Region

Japan


Condition

Condition

Social Anxiety.

Classification by specialty

Psychosomatic Internal Medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to explore the feasibility and potential effectiveness of a psychoeducational web application based on a cognitive behavioral modification approach and designed for self directed use targeted at working adults who exhibit subthreshold social anxiety tendencies characterized by fear of interpersonal interactions in social situations.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change (difference) in SPIN total score from week 0 (baseline) to week 6

Key secondary outcomes

Secondary outcomes are as follows:

- Change (difference) from week 0 (baseline) in the SPIN total score at week 12 (follow-up)

- Change (difference) from pre-intervention baseline to post-intervention scores for the depression scale PHQ-9, social anxiety scale LSAS, quality of life scale EQ-5D-5L, and anxiety scale GAD-7 at weeks 6 and 12


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom Other

Interventions/Control_1

web-based app education based on cognitive behavioral theory

Interventions/Control_2

No treatment(During the exam period, access the web daily and enter information such as the day's weather.)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1) Individuals aged 18 years or older but under 65 years at the time of consent.
2) Individuals who have never previously visited a psychiatrist or psychosomatic medicine specialist and are not currently receiving treatment from one.
3) Individuals working 20 hours or more per week.
4) Individuals with a total score of 19 points or higher on the Social Phobia Inventory (SPIN).
5) Individuals who do not meet the diagnostic criteria for social anxiety disorder (based on the American Psychiatric Association's DSM-5-TR).
6) Individuals who, prior to participating in this trial, received explanations via web-based documents and video, and provided informed consent online of their own free will after achieving sufficient understanding.
7) Individuals with internet access and a computer environment capable of using web-based applications.

Key exclusion criteria

1) Individuals for whom contact with researchers is difficult.
2) Other individuals deemed unsuitable by the principal investigator or research collaborators for the safe conduct of this study.
3) Individuals at risk of suicide (those scoring 2 to 3 points on item 9 of the PHQ-9 depression scale, which assesses suicidal ideation).

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Chiba University Graduate School of Medicine

Division name

Department of Cognitive Behavioral Physiology

Zip code

260-8670

Address

1-8-1,Inohana, Chuo-ku, Chiba-shi, Chiba ,260-8670,Japan

TEL

043-226-2027

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Shuhei
Middle name
Last name Aoki

Organization

Chiba University Graduate School of Medicine

Division name

Department of Cognitive Behavioral Physiology

Zip code

260-8670

Address

1-8-1,Inohana, Chuo-ku, Chiba-shi, Chiba ,260-8670,Japan

TEL

043-226-2027

Homepage URL


Email

25fd1101@student.gs.chiba-u.jp


Sponsor or person

Institute

Department of Cognitive Behavioral Physiology ,Chiba University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Cognitive Behavioral Physiology ,Chiba University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University Graduate School of Medicine

Address

1-8-1,Inohana, Chuo-ku, Chiba-shi, Chiba ,260-8670,Japan

Tel

043-226-2027

Email

neurophys1@ML.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 03 Day

Date of IRB

2025 Year 12 Month 03 Day

Anticipated trial start date

2026 Year 02 Month 20 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 13 Day

Last modified on

2026 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069280